Please provide your email address to receive an email when new articles are posted on . A study compared the optical and refractive performance of an enhanced monofocal IOL vs. an aberration-free ...
Among many presentations during a hot topics session at the American Academy of Ophthalmology 2021 annual meeting, speakers discussed the first FDA approved therapy for thyroid eye disease and the ...
Please provide your email address to receive an email when new articles are posted on . At the virtual European Society of Cataract and Refractive Surgeons winter meeting, Gerd Auffarth, MD, PhD, ...
FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...
enVista Envy full range of vision intraocular lens (IOL) met all primary efficacy and safety endpoints in multicenter study Results show that enVista Envy IOLs deliver excellent visual performance, ...
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the launch of the Clareon ® family of intraocular lenses ...
The new full visual range IOL*1 delivers exceptional distance vision2 and 14% smaller readable print size vs PanOptix3 †. 93% of patients become free from glasses at all distances.#4 ‡ TECNIS Odyssey ...
The device is intended for primary implantation in the capsular bag, in the nondominant eye, after the fellow eye has already undergone successful implantation of a monofocal or monofocal toric IOL ...
The FDA approved a refillable ranibizumab implant for DME, offering a less frequent treatment alternative to monthly injections. A case series suggested a potential link between semaglutide and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback